Articles from BIOTECH Patent News (October 1, 2002)

1-30 out of 30 article(s)

Title	Type	Words
Affymetrix signs gene expression agreement with Schering-Plough.	Brief Article	204
AGY Therapeutics obtains United States patent.	Brief Article	148
Amgen wins dialysis arbitration against J&J, awarded $150 million.		221
Antisense chemistry interference involves Hybridon.		301
Cellomics announces issuance of cell-based screening patent.		353
Congress approves law to expand patent re-examinations.		460
Cyclis completes cancer licensing agreement with Beth Israel.		418
Digital Gene to use Accelrys' bioinformatics system.		579
Eidgenossische Technische Hochschule obtains United States patent.	Brief Article	163
Florida State University obtains United States patent.	Brief Article	168
Immunomedics obtains lymphoma antibody patent.		333
Instituto Mexicano del Petroleo obtains United States patent.	Brief Article	167
Introgen obtains patent for p53 targeted chemotherapy.		468
Japan Science and Technology obtains United States patent.	Brief Article	123
Lexicon discovers role of LG688 protein in inflammation.		486
Medical College of Georgia Research Institute obtains United States patent.	Brief Article	165
Medix licenses Immunomedics' carcinoembryonic antigen technology.		449
Metin Colpan obtains United States patent.	Brief Article	126
Millipore obtains United States patent.	Brief Article	141
NeoPharm to present liposome technology data.		588
Neurocrine and Taisho restructure diabetes agreement.		424
Oncologic obtains United States patent.	Brief Article	282
Patented method could overcome drug resistance in cancer.		470
Pharmaceutical Resources prevails in interference proceeding.		340
Pharmacopeia and Kowa form inflammation research collaboration.		349
ResMed sues Respironics for mask patent infringment.	Brief Article	160
Schering-Plough and Biogen settle royalty payment arbitrations.	Brief Article	199
U.S. Genomics awarded patent for DNA analysis methods.		415
University of Pennsylvania obtains United States patent.	Brief Article	164
Urologix benign prostatic hyperplasia patent lawsuit dismissed.		371